70/120
2.9 / 5 stars
All 120 Win/Lose results shown below
GMED Roast Me summary
GLOBUS MEDICAL INC (GMED). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Win.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
Trailing 1 year (4 quarters): 9 wins, 3 lossesLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseGMED / S&P -8.30% / 15.20% |
WinGMED / S&P 19.74% / 15.00% |
LoseGMED / S&P 50.00% / 50.40% |
| 2026-Q13/3 |
WinGMED / S&P -1.32% / -4.33% |
WinGMED / S&P 23.49% / 11.30% |
WinGMED / S&P 220.15% / 27.70% |
| 2025-Q43/3 |
WinGMED / S&P 52.45% / 2.65% |
WinGMED / S&P 16.65% / 9.00% |
WinGMED / S&P 422.67% / 13.40% |
| 2025-Q32/3 |
LoseGMED / S&P -2.97% / 8.12% |
WinGMED / S&P 11.75% / 4.61% |
WinGMED / S&P 376.92% / 13.45% |
| 2025-Q22/3 |
LoseGMED / S&P -19.37% / 10.94% |
WinGMED / S&P 17.43% / 4.83% |
WinGMED / S&P 828.57% / 10.63% |
| 2025-Q12/3 |
LoseGMED / S&P -11.50% / -4.27% |
WinGMED / S&P 32.26% / 4.98% |
WinGMED / S&P 116.13% / 10.57% |
| 2024-Q42/3 |
WinGMED / S&P 15.61% / 2.41% |
WinGMED / S&P 60.62% / 5.25% |
LoseGMED / S&P -29.91% / 6.15% |
| 2024-Q31/3 |
LoseGMED / S&P 4.45% / 5.89% |
WinGMED / S&P 102.10% / 5.89% |
LoseGMED / S&P -58.06% / 6.11% |
| 2024-Q22/3 |
WinGMED / S&P 27.68% / 4.28% |
WinGMED / S&P 103.89% / 5.38% |
LoseGMED / S&P -86.07% / 5.12% |
| 2024-Q11/3 |
LoseGMED / S&P 0.66% / 10.56% |
WinGMED / S&P 77.59% / 5.71% |
LoseGMED / S&P -68.53% / 5.59% |
| 2023-Q41/3 |
LoseGMED / S&P 7.33% / 11.69% |
WinGMED / S&P 53.34% / 6.81% |
LoseGMED / S&P -42.16% / 7.78% |
| 2023-Q32/3 |
LoseGMED / S&P -16.61% / -3.27% |
WinGMED / S&P 22.84% / 7.52% |
WinGMED / S&P 2.65% / -5.03% |
| 2023-Q22/3 |
LoseGMED / S&P 5.12% / 8.74% |
WinGMED / S&P 12.63% / 9.50% |
WinGMED / S&P 34.90% / -8.57% |
| 2023-Q12/3 |
LoseGMED / S&P -23.74% / 7.50% |
WinGMED / S&P 11.20% / 10.77% |
WinGMED / S&P 44.85% / -15.69% |
| 2022-Q42/3 |
WinGMED / S&P 24.68% / 7.56% |
LoseGMED / S&P 6.76% / 11.88% |
WinGMED / S&P 28.47% / -17.99% |
| 2022-Q31/3 |
WinGMED / S&P 6.11% / -4.88% |
LoseGMED / S&P 6.04% / 13.47% |
LoseGMED / S&P -16.57% / -1.41% |
| 2022-Q20/3 |
LoseGMED / S&P -23.91% / -16.10% |
LoseGMED / S&P 4.96% / 13.71% |
LoseGMED / S&P -17.22% / 11.04% |
| 2022-Q12/3 |
WinGMED / S&P 2.19% / -4.60% |
WinGMED / S&P 16.41% / 15.97% |
LoseGMED / S&P 14.29% / 42.23% |
| 2021-Q41/3 |
LoseGMED / S&P -5.77% / 11.03% |
WinGMED / S&P 21.43% / 15.00% |
LoseGMED / S&P 42.57% / 96.40% |
| 2021-Q32/3 |
LoseGMED / S&P -1.17% / 0.58% |
WinGMED / S&P 22.71% / 10.77% |
WinGMED / S&P 96.74% / 69.42% |
| 2021-Q23/3 |
WinGMED / S&P 25.72% / 8.55% |
WinGMED / S&P 24.15% / 6.58% |
WinGMED / S&P 109.30% / 51.81% |
| 2021-Q11/3 |
LoseGMED / S&P -5.44% / 6.17% |
WinGMED / S&P 4.14% / -1.06% |
LoseGMED / S&P -17.93% / 7.39% |
| 2020-Q42/3 |
WinGMED / S&P 31.70% / 12.15% |
WinGMED / S&P 0.47% / -3.72% |
LoseGMED / S&P -33.55% / -33.42% |
| 2020-Q32/3 |
LoseGMED / S&P 3.79% / 8.93% |
WinGMED / S&P 33.74% / -2.04% |
WinGMED / S&P -15.60% / -27.10% |
| 2020-Q22/3 |
LoseGMED / S&P 12.18% / 20.54% |
WinGMED / S&P 36.70% / -0.46% |
WinGMED / S&P -18.87% / -27.11% |
| 2020-Q12/3 |
LoseGMED / S&P -27.77% / -19.60% |
WinGMED / S&P 50.88% / 3.47% |
WinGMED / S&P 29.46% / -14.75% |
| 2019-Q42/3 |
WinGMED / S&P 15.18% / 9.07% |
WinGMED / S&P 10.15% / 5.36% |
LoseGMED / S&P -1.30% / 2.99% |
| 2019-Q31/3 |
WinGMED / S&P 20.85% / 1.70% |
LoseGMED / S&P -17.22% / 5.02% |
LoseGMED / S&P -23.78% / 0.21% |
| 2019-Q20/3 |
LoseGMED / S&P -14.39% / 4.30% |
LoseGMED / S&P -19.07% / 6.64% |
LoseGMED / S&P -20.90% / 8.65% |
| 2019-Q11/3 |
WinGMED / S&P 14.16% / 13.65% |
LoseGMED / S&P -19.71% / 8.12% |
LoseGMED / S&P -5.88% / 14.29% |
| 2018-Q42/3 |
LoseGMED / S&P -23.75% / -13.52% |
WinGMED / S&P 12.11% / 9.05% |
WinGMED / S&P 40.00% / 18.23% |
| 2018-Q33/3 |
WinGMED / S&P 12.49% / 7.71% |
WinGMED / S&P 13.33% / 10.21% |
WinGMED / S&P 30.00% / 19.06% |
| 2018-Q22/3 |
LoseGMED / S&P 1.28% / 3.43% |
WinGMED / S&P 13.46% / 9.03% |
WinGMED / S&P 20.72% / 14.46% |
| 2018-Q12/3 |
WinGMED / S&P 21.22% / -0.76% |
WinGMED / S&P 12.75% / 7.68% |
LoseGMED / S&P 9.17% / 12.46% |
| 2017-Q42/3 |
WinGMED / S&P 38.29% / 6.64% |
WinGMED / S&P 12.76% / 7.03% |
LoseGMED / S&P 1.85% / 13.82% |
| 2017-Q31/3 |
LoseGMED / S&P -10.35% / 4.48% |
WinGMED / S&P 10.19% / 5.68% |
LoseGMED / S&P -9.84% / 17.57% |
| 2017-Q22/3 |
WinGMED / S&P 11.92% / 3.09% |
WinGMED / S&P 7.03% / 4.83% |
LoseGMED / S&P -9.76% / 17.74% |
| 2017-Q12/3 |
WinGMED / S&P 19.39% / 6.07% |
WinGMED / S&P 5.09% / 3.67% |
LoseGMED / S&P -9.92% / 13.32% |
| 2016-Q42/3 |
WinGMED / S&P 9.92% / 3.82% |
WinGMED / S&P 3.53% / 2.09% |
LoseGMED / S&P -7.69% / 7.05% |
| 2016-Q32/3 |
LoseGMED / S&P -5.29% / 3.85% |
WinGMED / S&P 4.52% / 0.20% |
WinGMED / S&P 12.96% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | GMED total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 35.42% | 20.78% |
| Annualized return | 35.42% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | GMED total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 0.36% | 83.14% |
| Annualized return | 0.07% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | GMED total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 253.67% | 319.30% |
| Annualized return | 13.46% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |